- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07592494
Comparison of the Effects of Different Upper Extremity Aerobic Exercise Training Protocols on Arm Functional Capacity in Patients With Heart Failure With Cardiac Implantable Electronic Devices
29 juillet 2026 mis à jour par: Gamze Nur AHISKALI, Erol Olcok Corum Training and Research Hospital
- To determine the most suitable exercise protocol for upper extremity aerobic exercise training, a widely used type of aerobic exercise to improve reduced upper extremity functional capacity in individuals with CIED and HF.
- To investigate whether high-intensity intermittent upper extremity aerobic exercise training provides a more effective improvement in upper extremity functional capacity compared to moderate-intensity continuous upper extremity aerobic exercise training.
- To determine the effectiveness of different types of upper extremity aerobic exercise training compared to lower extremity aerobic training alone in individuals with CIED and HF.
Aperçu de l'étude
Statut
Recrutement
Les conditions
Type d'étude
Interventionnel
Inscription (Estimé)
36
Phase
- N'est pas applicable
Contacts et emplacements
Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.
Lieux d'étude
-
-
-
Çorum, Turquie (Türkiye)
- Recrutement
- Hitit University Erol Olcok Training and Research Hospital, Cardiac Rehabilitation Unit
-
Contact:
- Gamze Nur Ahiskali
- Numéro de téléphone: 905514128687
- E-mail: gmzahiskali@gmail.com
-
-
Critères de participation
Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
- Adulte plus âgé
Accepte les volontaires sains
Non
La description
Inclusion Criteria:
- Patients aged 18 and over with heart failure who are receiving Implantable Cardioverter Defibrillator (ICD) or Cardiac Resynchronization Therapy (CRT)
- At least 3 months have passed since device implantation and there have been no complications at the last device control
- Being in New York Heart Association (NYHA) Class II-III
- Patients without cooperation problems
- Patients who volunteer to participate in the study
Exclusion Criteria:
- Patients who have previously participated in a cardiac rehabilitation program and those who have completed less than 1 year since the program,
- Patients with a primary diagnosis of cardiomyopathy and those with heart failure secondary to cardiomyopathy,
- Patients with a history of shoulder pathologies that may restrict upper extremity movement before device implantation (such as severe pain around the shoulder, edema, or shoulder dislocation that restricts upper extremity movement),
- Patients with a history of shoulder surgery (patients with limitations in range of motion),
- Patients who have undergone mastectomy on the affected side or a cerebrovascular event resulting in arm involvement,
- Patients with decompensated heart failure,
- Patients with a history of ICD-incompatible shock,
- Patients with a history of unstable angina pectoris, acute myocardial infarction, or cardiac surgery within the last 3 months,
- Patients who have experienced acute atrial fibrillation, ventricular tachycardia, and ventricular fibrillation within the last 3 months,
- Patients with actively treated malignancy or collagen tissue disease receiving systemic steroids
- Patients with chronic kidney disease undergoing dialysis where volume load is unstable,
- Persistent ventricular arrhythmias during baseline cardiopulmonary exercise testing.
Plan d'étude
Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Comparateur actif: Groupe de contrôle
|
a total of 40 minutes, at workloads equivalent to 70-80% of peak oxygen consumption
|
|
Expérimental: High-Intensity Interval Group
|
total of 20 minutes, consisting of 5 minutes of warm-up, 3x2 minutes of high-intensity training at 80-90% of maximum workload, 2x2 minutes of active rest at 30-40% of maximum workload, and 5 minutes of cool-down
a total of 40 minutes, at workloads equivalent to 70-80% of peak oxygen consumption
|
|
Expérimental: Moderate Intensity Continuous Group
|
a total of 40 minutes, at workloads equivalent to 70-80% of peak oxygen consumption
a total of 20 minutes, consisting of 5 minutes of warm-up, 10 minutes at 70-80% of maximum workload, and 5 minutes of cool-down
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Maximal arm exercise capacity
Délai: baseline and 8 weeks
|
The outcome will be evaluated using an arm ergometer exercise test.
The test will begin with a 3-minute (unloaded) warm-up after rest.
Different protocols will be applied to male and female patients due to differences in strength capabilities.
Men will start rotating the ergometer with a 30-W workload, while women will start with a 20-W workload.
In both protocols, patients will be asked to maintain a rotation speed of 70 revolutions per minute (rpm) throughout the test.
Again, due to their different strength levels, the workload will be increased by 10W for men and 6W for women every minute.
|
baseline and 8 weeks
|
|
Functional arm exercise capacity
Délai: baseline and 8 weeks
|
The outcome will be evaluated using the 6 Minute Pegboard and Ring Test (6PBRT).
During the 6PBRT, participants are asked to move rings on a pegboard from the two lower holes to the two upper holes using both arms simultaneously for 6 minutes.
Standardized encouragement is given every minute during the test.
The number of rings moved over 6 minutes gives the total score of the test.
|
baseline and 8 weeks
|
|
Cardiorespiratory Fitness
Délai: baseline and 8 weeks
|
The Maximum Symptom-Limited Cardiopulmonary Exercise Test (CPET), the gold standard method for assessing cardiorespiratory fitness, will be performed on a bicycle ergometer (Corival CPET, Lode, Groningen, Netherlands).
During the test, the bicycle ergometer ramp test protocol will be applied (starting workload = 20 W / 20W increase every three minutes / maintaining a rotation speed of 60-70 rpm) (2).
During the CPET, heart rate (HR) and heart rhythm will be continuously monitored with a 12-channel ECG test system (Custo Cardio 200 BT system, CustoMed GmbH, Ottoburn, Germany).
|
baseline and 8 weeks
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Peripheral muscle strength
Délai: baseline and 8 weeks
|
The outcome will be measured using a hand dynamometer (Baseline Hydraulic Hand Dynamometer, Model: 12-0240, Fabrication Enterprises INC. White Plains, NY 10602 U.S.A.).
Measurements will be taken in a seated position with shoulder adduction, elbow 90° flexion, and forearm in neutral position.
Three repetitions will be performed for each side.
The averages for the right and left sides will be recorded for statistical analysis.
|
baseline and 8 weeks
|
|
Activities of Daily Living
Délai: baseline and 8 weeks
|
The outcome will be assessed using the Performance Measure for Activities of Daily Living-8 for Patients with Mild Symptomatic Heart Failure (PMADL-8).
PMADL-8, an ICF-based scale, has a total score ranging from 8 to 32, and a high score indicates the level of limitation in activities of daily living.
|
baseline and 8 weeks
|
|
Health-related quality of life
Délai: baseline and 8 weeks
|
MacNew Heart Disease Health-Related Quality of Life Questionnaire The questionnaire consists of three sub-dimensions and 27 items: a physical limitation scale, an emotional limitation scale, and a social functioning scale, with some items falling into more than one sub-dimension.
Questions are scored between 1 and 7.
The total score of the questionnaire is calculated by averaging the scores given to the sub-dimensions.
Higher scores indicate better quality of life.
|
baseline and 8 weeks
|
|
Disease-related quality of life
Délai: baseline and 8 weeks
|
Assessment of Quality of Life and Related Events Scale (AQUAREL) Developed specifically for patients with pacemakers, the scale consists of 5 main sections: chest pain, arrhythmia, dyspnea, exertion, and cognition.
The scale consists of 24 questions scored using a 5-point Likert system.
The total score ranges from 0 to 100.
A low score reflects a perception of poor health, loss of function, and the presence of pain, while a high score reflects a perception of good health, preserved function, and the absence of pain.
|
baseline and 8 weeks
|
Collaborateurs et enquêteurs
C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.
Dates d'enregistrement des études
Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.
Dates principales de l'étude
Début de l'étude (Réel)
11 mai 2026
Achèvement primaire (Estimé)
11 mai 2027
Achèvement de l'étude (Estimé)
11 mai 2027
Dates d'inscription aux études
Première soumission
5 mai 2026
Première soumission répondant aux critères de contrôle qualité
11 mai 2026
Première publication (Réel)
18 mai 2026
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
31 juillet 2026
Dernière mise à jour soumise répondant aux critères de contrôle qualité
29 juillet 2026
Dernière vérification
1 mai 2026
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- 2026-02
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Non
Étudie un produit d'appareil réglementé par la FDA américaine
Non
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .